Chris has over 20 years of digital experience. From 2010 to 2015, he was the CEO of Travelzoo Inc. (NASDAQ:TZOO). During his tenure as CEO, revenues & audience grew rapidly and the company was named among Crain's and Glassdoor's Best Places to Work. From 2005 to 2010, he created and grew Travelzoo's European business. From 2001 to 2005, he served as Vice President of Business Development, creating successful digital demand products for the travel industry. Chris has been interviewed by Jim Cramer on CNBCs "Mad Money" several times. He has presented at digital conferences hosted by Goldman Sachs and JP Morgan Chase. In 2018, he addressed an audience of 4,000 pharmacists at Cardinal Health's Annual RBC Convention. Chris was named "Young Entrepreneur of the Year" in 2009 by the British Travel Industry Hall of Fame and Barclays Commercial, and "the Alumni Who Questions the Status Quo" by alumni of the University of California, Haas School of Business. He served on the National Leadership Board of the Blanton Museum of Art at the University of Texas and sits on the Board of Directors of YPO Austin Chapter as the Education Chair. Chris has dual MBAs from the University of California, Haas School of Business and Columbia Business School.
Chief Financial Officer
Judd Rabb oversees the company’s administrative and financial functions. Judd has over 20 years of experience working in high-growth technology startups. Prior to Digital Pharmacist, Judd was SVP Finance at Main Street Hub. From 2005 to 2014, Judd was CFO at various companies including Innovari, Solarbridge Technologies (acquired by SunPower), Illumitex, and Coldwatt (acquired by Flextronics). From 1999 to 2005, Judd was Corporate Controller at Silicon Labs, where he supported the company through its IPO, and Green Mountain Energy, where he supported the company through its sale to NRG. Judd started his career at Pricewaterhouse Coopers from 1989 to 1992. Judd earned a BBA in accounting from Texas A&M University, and is a Certified Public Accountant in the state of Texas.
Chief Technology Officer
Alan oversees product development, systems integration and architecture. Prior to joining Digital Pharmacist, Alan was Vice President Data & Knowledge at McKesson Specialty Health, where he lead product, engineering, business intelligence and quality assurance. In this role, he built and managed a team of 100 technologists. From December 2005 to May 2010, Alan was senior technical consultant at Optaros. From January 2003 to December 2005, he served as Manager, Platform Development at ZANTAZ. Alan holds a Bachelor of Science in Computer Engineering from the University of Missouri-Rolla.
Val oversees system design and architecture, development of voice, communication and digital solutions for the company. Prior for joining Digital Pharmacist, Val was a co-founder and Chief Technology Officer of TeleManager Technologies, where he was in charge of design and development of iRefill Connect cloud-based suite of products.
Prior to founding TeleManager Technologies, Val from 1989 to 1992 was with Brooklyn Union Gas Company, where he as a member of the Joint Project Team with Andersen Consulting Co. developed and implemented a New Customer System using state of the art Object Oriented Technology. Prior to that he served as a System Analyst with ADP Brokerage Information Services Group. Val received his MBA Degree in Information Technology from Odessa Merchant Marine Engineering Academy in Ukraine.
Krishna Srinivasan is a co-founder of LiveOak Venture Partners and has been investing in early stage Texas based companies and entrepreneurs since 2000.
Prior to founding LiveOak, Krishna was a Partner at Austin Ventures. Before joining Austin Ventures, Krishna was with Motorola where he wrote large scale optimization software for supply chain planning and worked with a variety of business units on strategic and operational issues. He started his professional career at SEMATECH.
Krishna received his MBA from Wharton where he graduated with highest academic honors as a Palmer Scholar. He also has an MS in Operations Research from the University of Texas at Austin, and a BS in Mechanical Engineering from the Indian Institute of Technology, where he graduated with the highest all-round honors.
Mr. Pietri co-founded Milestone Venture Partners with Ed Goodman in 1999 and became Managing Partner in 2014. Todd has helped guide several Milestone portfolio companies to a successful exit, including Derivatives Portfolio Management (sold to Mellon Financial in February 2005), MedPage Today (sold to Everyday Health in December 2010, which in turn went public in March 2014), Octagon Research Solutions (sold to Accenture, Inc. in August 2012), MapMyFitness (sold to UnderArmour, Inc. in December 2013) and GQ Life Sciences (sold to Aptean, Inc. in September 2016). He currently supervises MDX Medical (“Vitals”), YouNow, BA-Insight, Halfpenny Technologies, SHYFT Analytics, Cureatr, RxWiki and Healthify.
From 1992 to 1997, he ran IT consulting and direct sales for CompuSystems, an Atlanta-based ERP software and services firm focused on industrial distributors and manufacturers. Prior to his tenure at CompuSystems, Todd worked in the voice processing software industry for Innovative Technology, Call Response Automation and his own consulting firm.
Todd received his BA (cum laude) in English from Duke University in 1989. While working full-time for CompuSystems, Todd earned his MBA from the Robinson School of Business at Georgia State University in 1997, graduating first in his class. He is also CFA charterholder. He is a regular guest lecturer on venture capital at The Johnson School, Cornell University’s MBA program. He is also an advisory board member of NYC Seed, a public and private joint venture which provides capital and support to NYC-based seed stage entrepreneurs.
Matthew Ferrante Ph.D. is President and founder of Prime Time Medical Software, the leading provider of patient interviewing technology.
Mr. Frishauf founded three New York City-based medical information companies, F&F Publications in 1975, SCP Communications in 1982, and Medscape in 1995. He served as Medscape’s CEO until February, 1998 when he became Chairman of its Executive Committee and was a member of its Board of Directors through its IPO and until its merger with MedicaLogic/Medscape, Inc. in May, 2000. MedicaLogic sold Medscape to WebMD in December, 2001. Peter continues to contribute to the site as a writer and editorialist. SCP was acquired by CMP Healthcare Media in 2004. Peter is a director and past president of the Healthcare Marketing & Communications Council, Inc.; a director of MedPage Today, a site that covers breaking medical news peer-reviewed by the University of Pennsylvania; a director of The Ominmedix Institute, a healthcare information technology consultancy; and president of Alumni & Friends of LaGuardia High School of Music & Art and Performing Arts. Peter holds a BA from New York University’s Washington Square College and an MS in Journalism from Columbia University Graduate School of Journalism.